{"meta":{"query_hash":"e9ba3189121d","filters":{"venue":"Clinical Prostate Cancer"},"cohort_total":6,"direct_labels_cover":0,"predictions_cover":6,"exported":6,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e9ba3189121d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Prostate+Cancer"},"results":[{"id":"W2001143432","doi":"10.3816/cgc.2003.n.017","title":"Active Surveillance with Selective Delayed Intervention: A Biologically Nuanced Approach to Favorable-Risk Prostate Cancer","year":2003,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Watchful waiting; Medicine; Prostate cancer; Disease; Intervention (counseling); Internal medicine; Prostate-specific antigen; Oncology; Cancer; Intensive care medicine","score_opus":0.08358071807234146,"score_gpt":0.4218320146886531,"score_spread":0.33825129661631165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001143432","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001967281,0.9759401,0.00014997463,0.0003263159,0.0009867406,0.013631927,0.005228048,0.000240345,0.0015292317],"genre_scores_gemma":[0.0011155917,0.9693047,0.0012993149,0.0009830052,0.00052187336,0.022629883,0.0009990882,0.00029662022,0.0028499356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99055517,0.0013165761,0.0028786128,0.003111984,0.0006696778,0.0014680094],"domain_scores_gemma":[0.99324524,0.00086322107,0.0023769059,0.001176526,0.001222206,0.00111588],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0013822682,0.0016564383,0.0059008356,0.00026281315,0.00029454945,0.0001306571,0.00045885888,0.00086337555,0.00023162297],"category_scores_gemma":[0.0004465939,0.0010408662,0.0015572645,0.0018242052,0.0005683666,0.00018790638,0.00021326971,0.0023328823,0.00010749688],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00425237,0.002105199,0.013394675,0.0066277254,0.005271056,0.000106764965,0.00028814218,0.00007768082,3.1489762e-7,0.00002105549,0.005537692,0.96231735],"study_design_scores_gemma":[0.00694521,0.0067378557,0.0032743942,0.020284746,0.0039261268,0.00006406656,0.000110073466,0.000013507656,0.000015126454,0.000064323074,0.95700866,0.0015559061],"about_ca_topic_score_codex":0.0005294241,"about_ca_topic_score_gemma":0.000335365,"teacher_disagreement_score":0.9607614,"about_ca_system_score_codex":0.0024444098,"about_ca_system_score_gemma":0.0031129343,"threshold_uncertainty_score":0.99996877},"labels":[],"label_agreement":null},{"id":"W2011246519","doi":"10.3816/cgc.2005.n.002","title":"Combined Androgen Blockade: The Case for Bicalutamide","year":2005,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre","funders":"","keywords":"Bicalutamide; Antiandrogen; Flutamide; Medicine; Prostate cancer; Castration; Urology; Antiandrogens; Internal medicine; Enzalutamide; Androgen; Oncology; Androgen receptor; Hazard ratio; Androgen deprivation therapy; Randomized controlled trial; Testosterone (patch); Combination therapy; Endocrinology; Cancer; Hormone; Confidence interval","score_opus":0.23588876844973317,"score_gpt":0.5315328612553668,"score_spread":0.29564409280563364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011246519","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017537046,0.98495823,0.000004904529,0.0038747664,0.0008373885,0.008707707,0.0010771021,0.00010261388,0.00026191882],"genre_scores_gemma":[0.00004122584,0.9750699,0.0001285909,0.00070097373,0.0024586655,0.0044044936,0.00044633562,0.00016991027,0.016579911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958071,0.00032555338,0.0016935644,0.0009863625,0.00032802648,0.00085936463],"domain_scores_gemma":[0.99564934,0.0019971104,0.00050543534,0.0009652798,0.00032671768,0.0005561389],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013056246,0.0006393914,0.0027713594,0.00012008257,0.00031883718,0.000080287304,0.00035063858,0.00064272754,0.00035179165],"category_scores_gemma":[0.00048635484,0.0003235046,0.0016859064,0.00046035295,0.0007295265,0.00006076534,0.0001903803,0.0013763559,0.00013473656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005929527,0.00028784125,0.000088348985,0.008715816,0.0010850868,0.0014094115,0.000034336932,4.2281778e-7,9.2158395e-8,0.000023604305,0.021010198,0.9667519],"study_design_scores_gemma":[0.00430902,0.00090445805,0.000008440867,0.0056089223,0.00400704,0.00069442316,0.000025200356,0.000039203107,0.0000026551543,0.000080972524,0.9839464,0.0003732758],"about_ca_topic_score_codex":0.00003486376,"about_ca_topic_score_gemma":0.000037675913,"teacher_disagreement_score":0.9663786,"about_ca_system_score_codex":0.000473576,"about_ca_system_score_gemma":0.0022493275,"threshold_uncertainty_score":0.9999217},"labels":[],"label_agreement":null},{"id":"W2021847075","doi":"10.1016/s1540-0352(11)70082-8","title":"Role of Magnetic Resonance Spectroscopic Imaging in the Prediction of Treatment Outcome in Prostate Cancer","year":2004,"lang":"en","type":"letter","venue":"Clinical Prostate Cancer","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Institute for Biodiagnostics","funders":"","keywords":"Medicine; Magnetic resonance imaging; Nuclear medicine; Prostate cancer; Effective diffusion coefficient; Prostate; Standard deviation; Rectum; Flip angle; Radiology; Cancer; Internal medicine; Mathematics","score_opus":0.04778675804492902,"score_gpt":0.3836048825484688,"score_spread":0.33581812450353976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021847075","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37990615,0.09176697,7.9432e-7,0.5169854,0.001616717,0.006809695,0.0020742042,0.000055556186,0.0007845192],"genre_scores_gemma":[0.3883591,0.3001785,0.0003915962,0.28929797,0.005690619,0.010422895,0.00055075943,0.000403743,0.004704834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948941,0.0003095249,0.002517161,0.0009452353,0.00062983437,0.00070413365],"domain_scores_gemma":[0.9973903,0.0005635141,0.00083736196,0.00093514257,0.00019193153,0.00008177945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066825637,0.000521133,0.001606665,0.00029228223,0.000028558883,0.000017369815,0.00034984102,0.000416122,0.00037854523],"category_scores_gemma":[0.0001346894,0.00037208997,0.00035762,0.0006006201,0.0005860321,0.00009538549,0.00006751498,0.0019203506,0.000007843189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045722595,0.0003668709,0.9297188,0.0009401967,0.00004272406,0.00017618429,0.0011796538,0.000097555465,0.000104301245,0.0000040041177,0.04101978,0.025892703],"study_design_scores_gemma":[0.00757914,0.0017731695,0.6616432,0.004920345,0.00040481114,0.000008929662,0.00016193224,0.00009361683,0.0005854565,0.0005632091,0.32194874,0.00031747425],"about_ca_topic_score_codex":0.007028084,"about_ca_topic_score_gemma":0.0013024049,"teacher_disagreement_score":0.28092894,"about_ca_system_score_codex":0.0023150775,"about_ca_system_score_gemma":0.0017087555,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W2030339269","doi":"10.3816/cgc.2005.n.009","title":"Clinical Benefit of Zoledronic Acid for the Prevention of Skeletal Complications in Advanced Prostate Cancer","year":2005,"lang":"en","type":"article","venue":"Clinical Prostate Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Bone pain; Internal medicine; Incidence (geometry); Placebo; Pathologic fracture; Oncology; Cancer; Surgery; Urology; Pathology","score_opus":0.07892006890509327,"score_gpt":0.4796531205865005,"score_spread":0.4007330516814072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030339269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97602344,0.010144052,0.00007485237,0.0092260735,0.00037497707,0.003696149,0.000317681,0.000022440927,0.00012031044],"genre_scores_gemma":[0.9801851,0.014518233,0.0013217985,0.00080747466,0.00014322074,0.0015322936,0.00006574716,0.00002996172,0.0013961847],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971678,0.000076076205,0.0018144549,0.00039851334,0.0001909856,0.0003521511],"domain_scores_gemma":[0.99782586,0.00057340984,0.00066242594,0.00043557014,0.00032520358,0.00017751551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008101013,0.0001618786,0.00067404634,0.000048688744,0.00006312781,0.000003648927,0.00012369535,0.00014407067,0.000077715544],"category_scores_gemma":[0.00024491784,0.00011232071,0.00032835404,0.00021473912,0.00032686332,0.00009412587,0.00004095263,0.0003504015,0.000007870466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016983841,0.0010693698,0.42726573,0.00027249893,0.0001453707,6.056246e-7,0.000120451834,0.00024184062,0.000097647986,0.00012321379,0.0003085676,0.5686563],"study_design_scores_gemma":[0.012691389,0.0014868025,0.9546622,0.0006462718,0.00030382854,0.0000016649916,0.000051615196,0.0012812916,0.0006236604,0.0006654831,0.027453061,0.00013271814],"about_ca_topic_score_codex":0.00017483697,"about_ca_topic_score_gemma":0.0017664918,"teacher_disagreement_score":0.5685236,"about_ca_system_score_codex":0.00014255378,"about_ca_system_score_gemma":0.0007009117,"threshold_uncertainty_score":0.45803055},"labels":[],"label_agreement":null},{"id":"W2086066681","doi":"10.3816/cgc.2002.n.016","title":"Zoledronic Acid Significantly Reduces Pathologic Fractures in Patients with Advanced-Stage Prostate Cancer Metastatic to Bone","year":2002,"lang":"en","type":"review","venue":"Clinical Prostate Cancer","topic":"Bone health and treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Zoledronic acid; Medicine; Prostate cancer; Osteonecrosis of the jaw; Bisphosphonate; Bone pain; Internal medicine; Cancer; Oncology; Osteoporosis; Surgery; Urology","score_opus":0.08720358540906437,"score_gpt":0.45070005960781934,"score_spread":0.36349647419875497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086066681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058954142,0.9272231,0.0000010804395,0.0004903919,0.00074229424,0.010495679,0.0018709955,0.000116045914,0.000106288],"genre_scores_gemma":[0.010561081,0.97688377,0.0005505491,0.0018748179,0.00014110777,0.0058099655,0.0005875068,0.00024194356,0.0033492462],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99252886,0.0005215433,0.0028497414,0.0018865066,0.000750188,0.001463166],"domain_scores_gemma":[0.9958161,0.00036289648,0.001466753,0.0009243122,0.00032220298,0.0011076975],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00064450473,0.0011935747,0.0049297544,0.00038390156,0.0001376716,0.00005156896,0.00028253338,0.0004814847,0.0006842889],"category_scores_gemma":[0.00037667406,0.00074974453,0.0005446292,0.0010108317,0.00031040717,0.00019523496,0.00012775998,0.001935602,0.00021439766],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016431096,0.0013722223,0.016900286,0.01016037,0.00041729244,0.00075595797,0.00021197724,0.000028447448,2.5464533e-7,0.0000011249758,0.000907282,0.96760166],"study_design_scores_gemma":[0.011306131,0.0053148675,0.025253212,0.033200826,0.002826086,0.000015961023,0.000045839522,0.0000038265093,0.000006801964,0.000019631936,0.92072904,0.0012777884],"about_ca_topic_score_codex":0.00017397657,"about_ca_topic_score_gemma":0.0003613163,"teacher_disagreement_score":0.9663239,"about_ca_system_score_codex":0.0010584894,"about_ca_system_score_gemma":0.0020791835,"threshold_uncertainty_score":0.9994953},"labels":[],"label_agreement":null},{"id":"W2142606098","doi":"10.3816/cgc.2003.n.018","title":"Salvage Cryosurgery for Recurrent Prostate Cancer After Radiation Therapy: A Seven-Year Follow-up","year":2003,"lang":"en","type":"article","venue":"Clinical Prostate Cancer","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":140,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cryosurgery; Prostate cancer; Radiation therapy; Cryoablation; Prostate; Urology; Prostate-specific antigen; Cancer; Surgery; Internal medicine","score_opus":0.05578848116549954,"score_gpt":0.3793201374604634,"score_spread":0.32353165629496383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142606098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92452675,0.057518996,0.000029195933,0.005383736,0.0053942404,0.005564215,0.0011314667,0.0001539395,0.00029743373],"genre_scores_gemma":[0.85745186,0.11767523,0.00031950438,0.0061946604,0.0008297234,0.012975693,0.00020726166,0.00016030048,0.00418578],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962759,0.00020925298,0.0011997662,0.0010538367,0.00040730523,0.00085393747],"domain_scores_gemma":[0.9975472,0.0004610514,0.000433682,0.0005772048,0.00045725223,0.0005236295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009548849,0.00049627793,0.0009753464,0.00011265503,0.0001533809,0.00007625325,0.00010363066,0.00021883076,0.00082491804],"category_scores_gemma":[0.0003978531,0.0003885942,0.00065562787,0.00034293302,0.00020146884,0.00021922159,0.000033797365,0.00041591196,0.000051865652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010776074,0.0009302356,0.5969765,0.00031668076,0.00070165115,0.000048265694,0.0009448069,0.00001544297,0.00007616119,0.00008684581,0.037886687,0.35124063],"study_design_scores_gemma":[0.023824275,0.0029733032,0.1966823,0.0008420985,0.00050702156,0.000005744905,0.00013071366,0.000052905576,0.0035253356,0.000911469,0.7697982,0.0007465999],"about_ca_topic_score_codex":0.00006436805,"about_ca_topic_score_gemma":0.00010014861,"teacher_disagreement_score":0.73191154,"about_ca_system_score_codex":0.00061546726,"about_ca_system_score_gemma":0.0011627516,"threshold_uncertainty_score":0.9998566},"labels":[],"label_agreement":null}]}